Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis

Table 3 Demographic and Clinical Features of Critical Patients

	Critical 1	Critical 2	Critical 3	Critical 4	Critical 5	Critical 6	Critical 7	Critical 8	Aggregate
Sex	Male	Male	Female	Male	Male	Male	Male	Female	6/8 Male
Age (years)	6.50	0.17	0.21	2.58	1.08	2.25	8.00	0.87	Median 1.67 years old
Ventilator	No	No	Yes	No	Yes	No	Yes	Yes	4/8
PCR	Pos	Pos	Neg	Neg	Neg	Pos	Pos	Pos	5/8
Imaging changes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	8/8
Dyspnoea	No	Yes	Yes	No	Yes	Yes	No	Yes	5/8
Cough	Yes	Yes	Yes	No	No	Yes	Yes	No	5/8
Fever	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	8/8
Gastrointestinal symptoms	Yes	No	Yes	No	No	No	No	Yes	3/8
Comorbidities
Acute lymphoblastic leukemia	Yes	No	No	No	No	No	Yes	No	2/8
Intussusception	No	No	No	No	No	No	No	Yes	1/8
Complications
Hemophagocytic lymphohistiocytosis	No	No	No	Yes	No	No	No	No	1/8
Spesis	No	No	No	No	Yes	No	Yes	Yes	3/8
Non-infectious multiple organ ysfunction syndrome (MODS)	No	No	No	No	Yes	No	No	Yes	1/8
Cardiac dysfunction	No	No	No	Yes	Yes	No	Yes	No	3/8
Renal dysfunction	No	Yes	No	Yes	Yes	No	No	No	3/8
Abnormal liver function	No	Yes	No	Yes	No	No	No	No	2/8
Coagulation disorders	No	No	No	Yes	No	No	No	Yes	2/8
Epilepsy	No	No	No	No	No	No	No	Yes	1/8